Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (De

Noji, Satoru; Hara, Yoshinori; Miura, Tomoya; Yamanaka, Hiroshi; Maeda, Katsuya; Hori, Akimi; Yamamoto, Hiroshi; Obika, Shingo; Inoue, Masafumi; Hase, Yasunori; Orita, Takuya; Doi, Satoki; Adachi, Tsuyoshi; Tanimoto, Atsuo; Oki, Chika; Kimoto, Yukari; Ogawa, Yoshihiro; Negoro, Tamotsu; Hashimoto, Hiromasa; Shiozaki, Makoto

doi:10.1021/acs.jmedchem.0c00450

Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (De

Journal Article · Mon Jun 01 00:00:00 EDT 2020 · J. Med. Chem.

DOI:https://doi.org/10.1021/acs.jmedchem.0c00450· OSTI ID:1833688

Noji, Satoru; Hara, Yoshinori; Miura, Tomoya; Yamanaka, Hiroshi; Maeda, Katsuya; Hori, Akimi; Yamamoto, Hiroshi; Obika, Shingo; Inoue, Masafumi; Hase, Yasunori; Orita, Takuya; Doi, Satoki; Adachi, Tsuyoshi; Tanimoto, Atsuo; Oki, Chika; Kimoto, Yukari; Ogawa, Yoshihiro; Negoro, Tamotsu; Hashimoto, Hiromasa; Shiozaki, Makoto

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; FOREIGN

OSTI ID:: 1833688

Journal Information:: J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (13) Vol. 63

Country of Publication:: United States

Language:: ENGLISH

References (50)

Stereocontrolled Synthesis of 3-Substituted Azetidinic Amino Acids Sivaprakasam, Mangaleswaran; Couty, François; Evano, Gwilherm Synlett, Issue 5 https://doi.org/10.1055/s-2006-933125	journal	January 2006
Adverse effects of topical glucocorticosteroids Hengge, Ulrich R.; Ruzicka, Thomas; Schwartz, Robert A. Journal of the American Academy of Dermatology, Vol. 54, Issue 1 https://doi.org/10.1016/j.jaad.2005.01.010	journal	January 2006
Characterization of a 2,4-Dinitrochlorobenzene-Induced Chronic Dermatitis Model in Rats Fujii, Y.; Takeuchi, H.; Sakuma, S. Skin Pharmacology and Physiology, Vol. 22, Issue 5 https://doi.org/10.1159/000235551	journal	January 2009
Synthesis of Model Compound Containing an Indole Spiro-β-lactam Moiety with Vinylchloride in Chartellines Nishikawa, Toshio; Kajii, Shigeo; Isobe, Minoru Chemistry Letters, Vol. 33, Issue 4 https://doi.org/10.1246/cl.2004.440	journal	April 2004
The many roles of molecular complexity in drug discovery Méndez-Lucio, Oscar; Medina-Franco, José L. Drug Discovery Today, Vol. 22, Issue 1 https://doi.org/10.1016/j.drudis.2016.08.009	journal	January 2017
Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design Wang, Xiaojing; Magnuson, Steven; Pastor, Rich Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 11 https://doi.org/10.1016/j.bmcl.2013.04.020	journal	June 2013
Atopic dermatitis Weidinger, Stephan; Beck, Lisa A.; Bieber, Thomas Nature Reviews Disease Primers, Vol. 4, Issue 1 https://doi.org/10.1038/s41572-018-0001-z	journal	June 2018
Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor Changelian, P. S. Science, Vol. 302, Issue 5646 https://doi.org/10.1126/science.1087061	journal	October 2003
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases: Miniperspective Clark, James D.; Flanagan, Mark E.; Telliez, Jean-Baptiste Journal of Medicinal Chemistry, Vol. 57, Issue 12 https://doi.org/10.1021/jm401490p	journal	January 2014
Regulation of JAK–STAT signalling in the immune system Shuai, Ke; Liu, Bin Nature Reviews Immunology, Vol. 3, Issue 11 https://doi.org/10.1038/nri1226	journal	November 2003
Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study Nakagawa, Hidemi; Nemoto, Osamu; Igarashi, Atsuyuki Journal of the American Academy of Dermatology, Vol. 82, Issue 4 https://doi.org/10.1016/j.jaad.2019.12.015	journal	April 2020
Ligand efficiency indices for effective drug discovery Abad-Zapatero, Cele Expert Opinion on Drug Discovery, Vol. 2, Issue 4 https://doi.org/10.1517/17460441.2.4.469	journal	April 2007
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Darnell, J.; Kerr, I.; Stark, G. Science, Vol. 264, Issue 5164 https://doi.org/10.1126/science.8197455	journal	June 1994
Long‐term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis Nakagawa, Hidemi; Nemoto, Osamu; Igarashi, Atsuyuki The Journal of Dermatology, Vol. 47, Issue 2 https://doi.org/10.1111/1346-8138.15173	journal	December 2019
The burden of skin disease in the United States Lim, Henry W.; Collins, Scott A. B.; Resneck, Jack S. Journal of the American Academy of Dermatology, Vol. 76, Issue 5 https://doi.org/10.1016/j.jaad.2016.12.043	journal	May 2017
Guidelines of care for the management of psoriasis and psoriatic arthritis Menter, Alan; Korman, Neil J.; Elmets, Craig A. Journal of the American Academy of Dermatology, Vol. 60, Issue 4 https://doi.org/10.1016/j.jaad.2008.12.032	journal	April 2009
Signaling by IL-31 and functional consequences Cornelissen, Christian; Lüscher-Firzlaff, Juliane; Baron, Jens Malte European Journal of Cell Biology, Vol. 91, Issue 6-7 https://doi.org/10.1016/j.ejcb.2011.07.006	journal	June 2012
Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model Yamamoto, Yasuo; Otsuka, Atsushi; Nakashima, Chisa Journal of Dermatological Science, Vol. 97, Issue 2 https://doi.org/10.1016/j.jdermsci.2019.12.008	journal	February 2020
Guidelines for treatment of atopic eczema (atopic dermatitis) Part I: Guidelines for treatment of atopic eczena Ring, J.; Alomar, A.; Bieber, T. Journal of the European Academy of Dermatology and Venereology, Vol. 26, Issue 8 https://doi.org/10.1111/j.1468-3083.2012.04635.x	journal	July 2012
Atopic dermatitis Weidinger, Stephan; Novak, Natalija The Lancet, Vol. 387, Issue 10023 https://doi.org/10.1016/S0140-6736(15)00149-X	journal	March 2016
A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents Tanimoto, Atsuo; Shinozaki, Yuichi; Yamamoto, Yasuo Experimental Dermatology, Vol. 27, Issue 1 https://doi.org/10.1111/exd.13370	journal	July 2017
Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids Bewley, A. British Journal of Dermatology, Vol. 158, Issue 5 https://doi.org/10.1111/j.1365-2133.2008.08479.x	journal	May 2008
The role of ligand efficiency metrics in drug discovery Hopkins, Andrew L.; Keserü, György M.; Leeson, Paul D. Nature Reviews Drug Discovery, Vol. 13, Issue 2 https://doi.org/10.1038/nrd4163	journal	January 2014
Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection Flanagan, Mark E.; Blumenkopf, Todd A.; Brissette, William H. Journal of Medicinal Chemistry, Vol. 53, Issue 24 https://doi.org/10.1021/jm1004286	journal	December 2010
Mechanisms regulating skin immunity and inflammation Pasparakis, Manolis; Haase, Ingo; Nestle, Frank O. Nature Reviews Immunology, Vol. 14, Issue 5 https://doi.org/10.1038/nri3646	journal	April 2014
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease O'Shea, John J.; Plenge, Robert Immunity, Vol. 36, Issue 4 https://doi.org/10.1016/j.immuni.2012.03.014	journal	April 2012
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo Kremer, Joel M.; Bloom, Bradley J.; Breedveld, Ferdinand C. Arthritis & Rheumatism, Vol. 60, Issue 7 https://doi.org/10.1002/art.24567	journal	July 2009
Therapeutic pipeline for atopic dermatitis: End of the drought? Paller, Amy S.; Kabashima, Kenji; Bieber, Thomas Journal of Allergy and Clinical Immunology, Vol. 140, Issue 3 https://doi.org/10.1016/j.jaci.2017.07.006	journal	September 2017
JAK Inhibitors for Atopic Dermatitis: An Update He, Helen; Guttman-Yassky, Emma American Journal of Clinical Dermatology, Vol. 20, Issue 2 https://doi.org/10.1007/s40257-018-0413-2	journal	December 2018
Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6 Chrencik, Jill E.; Patny, Akshay; Leung, Iris K. Journal of Molecular Biology, Vol. 400, Issue 3 https://doi.org/10.1016/j.jmb.2010.05.020	journal	July 2010
Utility of animal models for identification of potential therapeutics for rheumatoid arthritis Hegen, M.; Keith, J. C.; Collins, M. Annals of the Rheumatic Diseases, Vol. 67, Issue 11 https://doi.org/10.1136/ard.2007.076430	journal	November 2007
Methyl Scanning: Total Synthesis of Demethylasterriquinone B1 and Derivatives for Identification of Sites of Interaction with and Isolation of Its Receptor(s) Pirrung, Michael C.; Liu, Yufa; Deng, Liu Journal of the American Chemical Society, Vol. 127, Issue 13 https://doi.org/10.1021/ja044325h	journal	March 2005
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases Schwartz, Daniella M.; Kanno, Yuka; Villarino, Alejandro Nature Reviews Drug Discovery, Vol. 16, Issue 12 https://doi.org/10.1038/nrd.2017.201	journal	November 2017
The translational revolution and use of biologics in patients with inflammatory skin diseases Noda, Shinji; Krueger, James G.; Guttman-Yassky, Emma Journal of Allergy and Clinical Immunology, Vol. 135, Issue 2 https://doi.org/10.1016/j.jaci.2014.11.015	journal	February 2015
Cytokine Signaling in 2002 O'Shea, John J.; Gadina, Massimo; Schreiber, Robert D. Cell, Vol. 109, Issue 2 https://doi.org/10.1016/S0092-8674(02)00701-8	journal	April 2002
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID) Macchi, Paolo; Villa, Anna; Giliani, Silvia Nature, Vol. 377, Issue 6544 https://doi.org/10.1038/377065a0	journal	September 1995
TNF-α and Th2 Cytokines Induce Atopic Dermatitis–Like Features on Epidermal Differentiation Proteins and Stratum Corneum Lipids in Human Skin Equivalents Danso, Mogbekeloluwa O.; van Drongelen, Vincent; Mulder, Aat Journal of Investigative Dermatology, Vol. 134, Issue 7 https://doi.org/10.1038/jid.2014.83	journal	July 2014
Identification of N -{ cis -3-[Methyl(7 H -pyrrolo[2,3- d ]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases Vazquez, Michael L.; Kaila, Neelu; Strohbach, Joseph W. Journal of Medicinal Chemistry, Vol. 61, Issue 3 https://doi.org/10.1021/acs.jmedchem.7b01598	journal	January 2018
The influence of drug-like concepts on decision-making in medicinal chemistry Leeson, Paul D.; Springthorpe, Brian Nature Reviews Drug Discovery, Vol. 6, Issue 11 https://doi.org/10.1038/nrd2445	journal	November 2007
The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis Bao, Lei; Zhang, Huayi; Chan, Lawrence S. JAK-STAT, Vol. 2, Issue 3 https://doi.org/10.4161/jkst.24137	journal	July 2013
Escape from Flatland 2: complexity and promiscuity Lovering, Frank MedChemComm, Vol. 4, Issue 3 https://doi.org/10.1039/c2md20347b	journal	January 2013
Topical tofacitinib for atopic dermatitis: a phase II a randomized trial Bissonnette, R.; Papp, K. A.; Poulin, Y. British Journal of Dermatology, Vol. 175, Issue 5 https://doi.org/10.1111/bjd.14871	journal	September 2016
The maximal affinity of ligands Kuntz, I. D.; Chen, K.; Sharp, K. A. Proceedings of the National Academy of Sciences, Vol. 96, Issue 18 https://doi.org/10.1073/pnas.96.18.9997	journal	August 1999
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success Lovering, Frank; Bikker, Jack; Humblet, Christine Journal of Medicinal Chemistry, Vol. 52, Issue 21 https://doi.org/10.1021/jm901241e	journal	November 2009
Immune response patterns in non-communicable inflammatory skin diseases Eyerich, K.; Eyerich, S. Journal of the European Academy of Dermatology and Venereology, Vol. 32, Issue 5 https://doi.org/10.1111/jdv.14673	journal	January 2018
ATP-Mediated Kinome Selectivity: The Missing Link in Understanding the Contribution of Individual JAK Kinase Isoforms to Cellular Signaling Thorarensen, Atli; Banker, Mary Ellen; Fensome, Andrew ACS Chemical Biology, Vol. 9, Issue 7 https://doi.org/10.1021/cb5002125	journal	May 2014
Improvement of spontaneous locomotor activity with JAK inhibition by JTE-052 in rat adjuvant-induced arthritis Tanimoto, Atsuo; Shinozaki, Yuichi; Nozawa, Keisuke BMC Musculoskeletal Disorders, Vol. 16, Issue 1 https://doi.org/10.1186/s12891-015-0802-0	journal	November 2015
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice Dillon, Stacey R.; Sprecher, Cindy; Hammond, Angela Nature Immunology, Vol. 5, Issue 7 https://doi.org/10.1038/ni1084	journal	June 2004
Psoriasis Boehncke, Wolf-Henning; Schön, Michael P. The Lancet, Vol. 386, Issue 9997 https://doi.org/10.1016/S0140-6736(14)61909-7	journal	September 2015
The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling Amano, Wataru; Nakajima, Saeko; Kunugi, Hayato Journal of Allergy and Clinical Immunology, Vol. 136, Issue 3 https://doi.org/10.1016/j.jaci.2015.03.051	journal	September 2015

Similar Records

Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)

Journal Article · Fri Dec 31 23:00:00 EST 2021 · ACS Med. Chem. Lett. · OSTI ID:1844738

Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitors

Journal Article · Sat Oct 01 00:00:00 EDT 2022 · Bioorg. Med. Chem. Lett. · OSTI ID:1900946

Development of Selective Covalent Janus Kinase 3 Inhibitors

Journal Article · Mon Aug 10 00:00:00 EDT 2015 · Journal of Medicinal Chemistry · OSTI ID:1430281

Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (De

Citation Formats

References (50)

Similar Records

Related Subjects